Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension — Stella

Recruiting

Back to Mild to Moderate Hypertension trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing Municipality

Key details

Phase

Safety & dosing

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.

Enrollment target

~234 participants

Started

January 2026

Primary completion

July 2026

Age range

18 Years – 75 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov